BFRA

Q: What is the price of Biofrontera (BFRA) today?

The current price of Biofrontera (BFRA) is $ 0.00. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Biofrontera (BFRA) pay dividends?

Biofrontera (BFRA) did not pay dividends over the past year.

Q: Is Biofrontera (BFRA) a good investment?

Biofrontera (BFRA) is currently trading at $ 0.00 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Biofrontera AG

Price

$ -

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

BFRA price

Biofrontera

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BFRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BFRA

review the fundamentals of Biofrontera shares

P/E

0.00

Sector: -4.09 Industry: -4.09

P/Receita (PSR)

0.00

Sector: -3.87 Industry: -3.87

P/BV

0.00

Sector: 1.89 Industry: 1.89

Dividend Yield (DY)

0.00%

Sector: - Industry: -

Payout

Sector: - Industry: -

Net Profit Margins

-14.76%

Sector: -39.07% Industry: -39.07%

Gross Margin

89.44%

Sector: 37.83% Industry: 37.83%

Margem Operacional

2.78%

Sector: -39.17% Industry: -39.17%

Margem EBIT

-92.79%

Sector: - Industry: -

Margem EBITDA

-92.79%

Sector: - Industry: -

EV/EBITDA

5.79

Sector: - Industry: -

EV/EBIT

5.79

Sector: - Industry: -

EV/EBITDA

0.00

Sector: -3.91 Industry: -3.91

EV/EBIT

0.00

Sector: -4.18 Industry: -4.18

P/Ativo

0.00

Sector: 1.39 Industry: 1.39

P/Cap Giro

Sector: - Industry: -

P/Ativo Circ Líq

Sector: - Industry: -

BVPS

181,659.48

Sector: 1.88 Industry: 1.88

EPS

-999,999.99

Sector: -2.04 Industry: -2.04

Giro de Ativos

0.08

Sector: - Industry: -

ROE

-893.55%

Sector: -61.00% Industry: -61.00%

ROIC

Sector: -2,142.55% Industry: -2,142.55%

ROA

-205.16%

Sector: -61.28% Industry: -61.28%

Dívida Líquida / Patrimônio

-1.82

Sector: - Industry: -

Dívida Líquida / EBITDA

5.79

Sector: - Industry: -

Dívida Líquida / EBIT

5.79

Sector: - Industry: -

Dívida Bruta / Patrimônio

0.13

Sector: - Industry: -

Patrimônio / Ativos

0.23

Sector: 0.42 Industry: 0.42

Passivos / Ativos

0.23

Sector: 0.38 Industry: 0.38

Liquidez Corrente

Sector: - Industry: -

CAGR Receitas 5 Anos

64.87%

Sector: - Industry: -

CAGR Lucros 5 Anos

23.43%

Sector: - Industry: -

Fundamentals BFRA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AZN	27.54	6.04	21.93%	1.73%	$286.16 B	17.19%
JNJ	26.01	6.74	25.92%	2.29%	$547.30 B	21.83%
NBIX	27.51	4.05	14.71%	0.00%	$13.17 B	16.73%
ABEO	4.20	1.88	44.71%	0.00%	$298.65 M	100.00%
PFE	19.27	1.61	8.35%	6.53%	$149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$365.48 B	5.79%
ACAD	9.54	3.04	31.86%	0.00%	$3.73 B	36.49%
ADMA	17.04	5.25	30.78%	0.00%	$2.50 B	28.80%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BFRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/25/2021	03/04/2021	0.10390000
Dividends	08/17/2020	08/24/2020	0.02360000
Dividends	03/19/2020	03/30/2020	0.02210000

ABOUT Biofrontera

Biofrontera AG

Average Investor10 user rating

4.0 (0 people)

States of America

29 years

Founded: 1997

2018

Time since IPO - 8 years

149

Employees

Biofrontera AG (States of America) is listed on the Nasdaq and has a market capitalization of $55.02 million, with shareholders equity totaling $5.15 trillion.

The company employs approximately 149 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Biofrontera AG reported $311.95 trillion in revenue, generating net income of $-46.03 trillion.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BFRA.

Market cap

$55.02 million

Net worth

$5.15 trillion

$ 5,151,625,168,378.40

Assets

$22.44 trillion

$ 22,437,037,247,130.00

Total Shares Outstanding

28.36 million

28,358,000

Average Daily Trading Volume

$2.18 billion

$ 2,175,704,951.59

Sector

Healthcare

Industry

Biotecnologia

BFRA

BFRA revenue and profits

Financial Results BFRA

DRAG THE FRAME TO SEE MORE DATA

BFRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

MCK - McKesson

$862.96 21,75% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$27.11 25,77% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$119.96 60,16% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$204.64 42,91% (12M)

P/E

27.54

1.73%

ROE

21.93%

P/BV

6.04

ABBV - AbbVie

$210.26 15,72% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

NVO - Novo Nordisk

$39.32 --43,26% (12M)

P/E

12.44

4.25%

ROE

51.50%

P/BV

6.41

MCK - McKesson

$862.96 21,75% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$27.11 25,77% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$119.96 60,16% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$204.64 42,91% (12 M)

P/L

27.54

1.73%

ROE

21.93%

P/VP

6.04

ABBV - AbbVie

$210.26 15,72% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

NVO - Novo Nordisk

$39.32 --43,26% (12 M)

P/L

12.44

4.25%

ROE

51.50%

P/VP

6.41

Frequently Asked Questions

What is the price of Biofrontera (BFRA) today?

The current price of Biofrontera (BFRA) is $ 0.00. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Biofrontera (BFRA) pay dividends?

Biofrontera (BFRA) did not pay dividends over the past year.

Is Biofrontera (BFRA) a good investment?

Biofrontera (BFRA) is currently trading at $ 0.00 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Biofrontera (BFRA) stock?

You can buy Biofrontera (BFRA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BFRA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Biofrontera (BFRA) yield today?

Over the past month, Biofrontera (BFRA) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Biofrontera (BFRA) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BFRA

Biofrontera AG

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BFRA

review the fundamentals of Biofrontera shares

P/E

P/Receita (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Margem Operacional

Margem EBIT

Margem EBITDA

EV/EBITDA

EV/EBIT

EV/EBITDA

EV/EBIT

P/Ativo

P/Cap Giro

P/Ativo Circ Líq

BVPS

EPS

Giro de Ativos

ROE

ROIC

ROA

Dívida Líquida / Patrimônio

Dívida Líquida / EBITDA

Dívida Líquida / EBIT

Dívida Bruta / Patrimônio

Patrimônio / Ativos

Passivos / Ativos

Liquidez Corrente

CAGR Receitas 5 Anos

CAGR Lucros 5 Anos

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

Biofrontera AG

States of America

29 years

2018

149

PROFIT X PRICE BFRA

Financial Results BFRA

BFRA cash flow

Asset, Revenue and Profit Growth - BFRA

BFRA balance sheet

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions